Medicinal products made from blood are important for the treatment of numerous injuries and diseases. Every year, blood and stem cell donation centres, pharmaceutical companies and healthcare facilities report data on the collection, manufacture, use, import, export and expiry of blood, blood products and stem cell preparations to the Paul-Ehrlich-Institut (PEI), Federal Institute for Vaccines and Biomedicines. The reports are made on the basis of Section 21 (1) of the Transfusion Act (Transfusionsgesetz, TFG) and Section 2 (1-3) of the Transfusion Act Reporting Ordinance (Transfusionsgesetz-Meldeverordnung, TFGMV). In its report, the Paul-Ehrlich-Institut provides information on the supply situation for blood, blood products and stem cell preparations in Germany for the year 2023.
Source: S.Toey/Shutterstock
In 2023, a total of 6,989,967 donations (whole blood, apheresis and autologous blood donations) were made in Germany. This means that the total number of donations increased by 6.8 per cent compared to the previous year. The increase in plasmapheresis donations for the collection of plasma for fractionation accounted for the largest share. An increase of 12.7 per cent was recorded here. The number of whole blood donations also increased by 2.6 per cent compared to 2022, with a total of 3,672,317 in 2023. After the number of whole blood donations fell steadily until 2020, it has remained relatively constant since then at an average of around 3.66 million.
In its 2023 report on the blood and blood product supply, the Paul-Ehrlich-Institut provides a transparent comparison of the production and consumption of blood products.
Updated: 07.03.2025
